| Financial Year |
March 31 2023 |
| Monetary Funds |
1,818,089,397.44 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
369,465,083.85 |
| Accounts Receivable |
4,634,137,522.45 |
| Advances to Suppliers |
130,030,241.22 |
| Other Receivables |
136,291,549.05 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,410,735,546.30 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,839,623.06 |
| Total Current Assets |
8,792,709,902.55 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
13,681,928.84 |
| Fixed Assetes |
589,425,930.98 |
| Under-construction Projects |
162,326,094.54 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
200,114,794.78 |
| R&D expenses |
3,879,379.35 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
17,389,443.54 |
| Deferred Income Tax Assets |
118,834,013.08 |
| Other Non-Current Assets |
9,760,196.19 |
| Sub-Total of Non-Current Assets |
1,117,858,061.35 |
| Total Assets |
9,910,567,963.90 |
| Short-Term Loans |
739,172,018.62 |
| Trading Financial liabilities |
-- |
| Notes Payable |
846,941,304.11 |
| Accounts Payable |
3,704,395,140.96 |
| Accounts Received In Advance |
793,603.20 |
| Employee Compensation Payable |
66,083,779.55 |
| Taxes Payable |
48,634,469.35 |
| Interest Payable |
-- |
| Dividend Payable |
1,119,734.10 |
| Other payables |
193,341,558.39 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
496,420.59 |
| Other Current Liabilities |
13,503,268.66 |
| Sub-Total of Current Liabilities |
5,750,080,443.09 |
| Long-term Loans |
200,146,666.67 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
236,739,977.23 |
| Total Liabilities |
5,986,820,420.32 |
| Paid-In Capital(Or Share Stock) |
682,694,505.00 |
| Capital Surplus |
1,957,207,777.06 |
| Surplus Reserve |
107,506,681.93 |
| LESS:Treasury Stock |
39,053,075.15 |
| Undistributed Profits |
1,114,891,785.88 |
| Minority Stockholder's Interest |
126,371,425.38 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,797,376,118.20 |
| Owner's Equity（Stockholder's Equity） |
3,923,747,543.58 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,910,567,963.90 |
